Identifying the risk of cancer-associated systemic sclerosis

Affiliations

¹ Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: alfredo.guillen@vallhebron.cat.
² Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

Editorial

Alfredo Guillen-Del-Castillo et al. Joint Bone Spine. 2023 Dec.

. 2023 Dec;90(6):105618.

doi: 10.1016/j.jbspin.2023.105618. Epub 2023 Jul 22.

¹ Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: alfredo.guillen@vallhebron.cat.
² Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

No abstract available

Keywords: Antibodies; Cancer; Interstitial lung disease; Risk factors; Systemic sclerosis.

Comment on

Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study.
Lopez L, Barnetche T, Galli G, Seneschal J, Blanchard E, Shipley E, Pellegrin JL, Lazaro E, Constans J, Duffau P, Schaeverbeke T, Richez C, Kostine M, Truchetet ME. Lopez L, et al. Joint Bone Spine. 2023 May;90(3):105555. doi: 10.1016/j.jbspin.2023.105555. Epub 2023 Feb 25. Joint Bone Spine. 2023. PMID: 36842760